Cargando…
Six versus 2 weeks treatment with doxycycline in European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blinded, randomised and placebo-controlled trial
BACKGROUND: There is limited evidence regarding optimal duration of antibiotic treatment in neuroborreliosis. We aimed to compare efficacy and safety of oral doxycycline for 2 and 6 weeks in European Lyme neuroborreliosis (LNB). METHODS: The trial had a randomised, double-blinded, placebo-controlled...
Autores principales: | Solheim, Anne Marit, Lorentzen, Åslaug Rudjord, Dahlberg, Audun Olav, Flemmen, Heidi Øyen, Brune, Synne, Forselv, Kristine Johanne Nordstrøm, Pripp, Are Hugo, Bø, Margrete Halvorsen, Eikeland, Randi, Reiso, Harald, Mygland, Åse, Ljøstad, Unn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606522/ https://www.ncbi.nlm.nih.gov/pubmed/35896378 http://dx.doi.org/10.1136/jnnp-2022-329724 |
Ejemplares similares
-
Patient‐reported outcome after treatment for definite Lyme neuroborreliosis
por: Eikeland, Randi, et al.
Publicado: (2020) -
Assessment of cognitive function, structural brain changes and fatigue 6 months after treatment of neuroborreliosis
por: Andreassen, Silje, et al.
Publicado: (2022) -
Cognitive function in patients with neuroborreliosis: A prospective cohort study from the acute phase to 12 months post treatment
por: Andreassen, Silje, et al.
Publicado: (2022) -
Enhancement of cranial nerves in Lyme neuroborreliosis: incidence and correlation with clinical symptoms and prognosis
por: Lindland, Elisabeth S., et al.
Publicado: (2022) -
Six versus two weeks treatment with doxycycline in Lyme neuroborreliosis: the protocol of a multicentre, non-inferiority, double-blinded and randomised controlled trial
por: Solheim, Anne Marit, et al.
Publicado: (2019)